Clinical trial
The STEMI Optimization Trial - Ischemic Postconditioning (DANAMI4-iPOST) and Intravascular Ultrasound Guided PCI in STEMI (DANAMI4-iSTEMI)
NCT04775914 is registered in ClinicalTrials.gov with Thomas Engstrom as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The STEMI Optimization Trial - Ischemic Postconditioning (DANAMI4-iPOST) and Intravascular Ultrasound Guided PCI in STEMI (DANAMI4-iSTEMI)
- Lead sponsor
- Thomas Engstrom
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2021
- Completion date
- February 1, 2031
- Enrollment
- 2,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.